Schrøder H, Møller J, Thomsen A, Skadborg R, Clausen N
Paediatrisk afdeling og klinisk kemisk afdeling, Arhus Kommunehospital.
Ugeskr Laeger. 1991 Dec 16;153(51):3615-8.
In a number of cases, neuroblastoma (NB) may be diagnosed by routine screening of the urine for vanillinic-mandelic acid (VMA) and homovanillinic acid (HVA) in symptomfree infants at the age of six months. Early diagnosis of this disease may possibly improve the prognosis. The object of this project was to establish a method of measuring VMA and HVA concentrations in urine collected on filter paper and to assess participation by the parents as regards three different methods of collecting urine with the object of establishing a population screening programme for NB in Denmark. A total of 1,111 infants aged 6-8 months participated in the investigation. The equipment for testing the urine was given in three different was: 1) By the health nurses (County of Arhus), 2) By the general practitioner at the 6-month vaccination (County of Ringkøbing) and 3) By post (County of Viborg). In Arhus, the health nurses delivered the equipment to 96.7% of the age group concerned. Altogether, urine samples were obtained from 673 infants (61%). Participation was greatest in the County of Arhus (66%) and the County of Ringkøbing (62%) and lowest in the County of Viborg (54%). Two infants were found with marginally raised VMA or HVA but these values were found to be normal on repeated examinations. No cases of neuroblastoma were found in the material nor in the screened group in the course of 1 1/2 years after the conclusion of the investigation. In just over 3% of the cases, renewed urine samples had to be sent on account of too little urine on the filter paper. If current population investigations reveal that screening for neuroblastoma can alter the course of the disease in children, the method described here may form the basis for introduction of population investigations in Denmark.
在许多情况下,神经母细胞瘤(NB)可通过对6个月无症状婴儿的尿液进行香草扁桃酸(VMA)和高香草酸(HVA)的常规筛查来诊断。该疾病的早期诊断可能会改善预后。本项目的目的是建立一种测量滤纸收集尿液中VMA和HVA浓度的方法,并评估父母对三种不同尿液收集方法的参与情况,以便在丹麦建立NB群体筛查项目。共有1111名6 - 8个月大的婴儿参与了调查。检测尿液的设备以三种不同方式提供:1)由健康护士(奥胡斯郡)提供,2)由全科医生在6个月疫苗接种时提供(灵克宾郡),3)通过邮寄提供(维堡郡)。在奥胡斯,健康护士向96.7%的相关年龄组提供了设备。总共从673名婴儿(61%)那里获得了尿液样本。参与率在奥胡斯郡(66%)和灵克宾郡(62%)最高,在维堡郡(54%)最低。发现两名婴儿的VMA或HVA略有升高,但这些值在复查时被发现是正常的。在调查结束后的1年半时间里,在该材料中以及筛查组中均未发现神经母细胞瘤病例。在略超过3%的病例中,由于滤纸上尿液过少,不得不再次寄送尿液样本。如果当前的群体调查表明神经母细胞瘤筛查可以改变儿童疾病进程,这里描述的方法可能成为丹麦引入群体调查的基础。